Two Onc Docs

ASCO 2023 is just around the corner and we are teaming up with The Fellow On Call to bring you a joint mini-series called “Paging Heme/Onc: Updates from ASCO 2023” where we’ll bring you brief, high-yield discussions of some of the research we found most interesting from this year’s conference.

This week’s episode is part 2 of our series focusing on transfusion medicine. We discuss indications for pre-transfusion protocols, as well as infectious and non-infectious, and acute & delayed risks of transfusions

This week’s episode is part 1 of a 2 part series focusing on transfusion medicine. In part 1, we cover important details on blood group systems, blood components, indications for these components, and quickly cover apharesis. 

This week’s episode will be focusing on thyroid cancers. We will go over details on the staging, breaking down the various types of thyroid cancers and of course the treatments for this disease group.

This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.

This week’s episode will be an introduction to plasma cell dyscrasias. We will cover the diagnostic criteria for MGUS and Smoldering Myeloma as well as introduce Multiple Myeloma.

Today we tackle inheritable bone marrow failure syndromes. We will go over the important details on the various types of testable bone marrow failure disorders including the key features of diagnosis and treatment.

This week’s episode will be focusing on cholangiocarcinoma, or biliary tract cancer. We will go over the testable high yield facts on the risk factors, diagnosis, and treatment of local and advanced cholangiocarcinoma.

This week’s episode will be focusing on syndromes of iron overload. We will go over important details on hemochromatosis and other related diseases, as well as iron chelation.

This week’s episode will be focusing on how we met, the future of the podcast, and different career paths in hematology and oncology. This is a very different style of episode and a special once because today is our one year anniversary of Two Onc Docs! We will back to our regular programming next week.